Trevi Therapeutics, Inc.
TRVI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001563880
In the last 90 days, Trevi Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 218 institutions reported holding it in 13F filings for Q2 2026, worth $2.76B in total; Viking Global Investors is the only superinvestor holding it.
13F holders, Q4 2022
Institutional positions in Trevi Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 37
- −3 vs. Q3 2022
- Shares held
- 43.2M
- −2.59M (−5.7%) vs. Q3 2022
- Total value
- $83.3M
- +$12.9M (+18.2%) vs. Q3 2022
- New holders
- 10
- 9 more added
- Sold out
- 13
- 8 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRVI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 218 | $2.76B |
| Q1 2026 | 198 | $1.61B |
| Q4 2025 | 184 | $1.63B |
| Q3 2025 | 164 | $1.18B |
| Q2 2025 | 154 | $627.2M |
| Q1 2025 | 137 | $554.3M |
| Q4 2024 | 110 | $329.5M |
| Q3 2024 | 93 | $194.1M |
| Q2 2024 | 77 | $166.6M |
| Q1 2024 | 80 | $177.9M |
| Q4 2023 | 63 | $70.0M |
| Q3 2023 | 55 | $106.1M |
| Q2 2023 | 53 | $116.7M |
| Q1 2023 | 36 | $80.4M |
| Q4 2022 | 37 | $83.3M |
| Q3 2022 | 40 | $70.5M |
| Q2 2022 | 32 | $80.8M |
| Q1 2022 | 23 | $32.9M |
| Q4 2021 | 17 | $10.3M |
| Q3 2021 | 18 | $17.4M |
| Q2 2021 | 17 | $28.1M |
| Q1 2021 | 19 | $35.6M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Trevi Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| NEA Management Company, LLC | 11,373,174 | $22.0M | 1.23% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 6,663,590 | $12.9M | 0.80% | +1,260,000+23.3% | Added |
| Fairmount Funds Management LLC | 5,696,515 | $11.0M | 1.74% | 00.0% | Unchanged |
| Rubric Capital Management LP | 5,684,420 | $11.0M | 0.48% | 00.0% | Unchanged |
| Viking Global Investors LPSuperinvestorViking Global Investors | 4,400,000 | $8.49M | 0.04% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,050,022 | $5.89M | 0.99% | 00.0% | Unchanged |
| MAI Capital Management | 1,720,676 | $3.32M | 0.06% | −298,488−14.8% | Reduced |
| Vanguard Group Inc | 1,439,593 | $2.78M | 0.00% | +115,216+8.7% | Added |
| Silverarc Capital Management, LLC | 767,631 | $1.48M | 0.51% | −171,634−18.3% | Reduced |
| Opaleye Management Inc. | 485,000 | $936.0K | 0.33% | +485,000 | New |
| Renaissance Technologies LLC | 318,000 | $614.0K | 0.00% | −101,187−24.1% | Reduced |
| Geode Capital Management, LLC | 211,547 | $408.0K | 0.00% | +11,326+5.7% | Added |
| Bridgeway Capital Management, LLC | 208,400 | $402.2K | 0.01% | +49,100+30.8% | Added |
| Millennium Management LLC | 157,624 | $304.0K | 0.00% | +117,663+294.4% | Added |
| Bank of Montreal | 152,300 | $293.9K | 0.00% | +152,300 | New |
| Tejara Capital Ltd | 149,958 | $289.4K | 0.17% | +149,958 | New |
| State Street Corp | 99,542 | $192.1K | 0.00% | +22,500+29.2% | Added |
| WealthTrust Axiom LLC | 93,500 | $180.5K | 0.06% | 00.0% | Unchanged |
| J. Goldman & Co LP | 89,188 | $172.1K | 0.01% | 00.0% | Unchanged |
| Innovis Asset Management LLC | 87,453 | $168.8K | 0.08% | +87,453 | New |
| BlackRock Inc. | 80,771 | $155.9K | 0.00% | +21,947+37.3% | Added |
| Northern Trust Corp | 54,115 | $104.4K | 0.00% | +14,188+35.5% | Added |
| Citadel Advisors LLC | 44,216 | $85.3K | 0.00% | +44,216 | New |
| Two Sigma Investments, LP | 28,653 | $55.3K | 0.00% | −50,784−63.9% | Reduced |
| United Bank | 28,450 | $54.9K | 0.01% | 00.0% | Unchanged |
| Atom Investors LP | 25,376 | $49.0K | 0.02% | +25,376 | New |
| Bailard, Inc. | 21,200 | $40.9K | 0.00% | +21,200 | New |
| Bank of New York Mellon Corp | 14,098 | $27.2K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 13,995 | $27.0K | 0.00% | +13,995 | New |
| Charles Schwab Investment Management Inc | 12,557 | $24.2K | 0.00% | 00.0% | Unchanged |
| LPL Financial LLC | 10,000 | $19.3K | 0.00% | −10,000−50.0% | Reduced |
| UBS Group AG | 3,091 | $5.97K | 0.00% | −1,186−27.7% | Reduced |
| First Manhattan Co | 500 | $965 | 0.00% | −1,000−66.7% | Reduced |
| Morgan Stanley | 439 | $848 | 0.00% | −427,966−99.9% | Reduced |
| Wells Fargo & Company | 261 | $504 | 0.00% | +122+87.8% | Added |
| Bank of America Corp | 92 | $178 | 0.00% | +92 | New |
| Simplex Trading, LLC | 10 | $0 | 0.00% | +10 | New |
| FMR LLC | 0 | $0 | 0.00% | −1,560,125−100.0% | Sold out |
| Altium Capital Management LP | 0 | $0 | 0.00% | −1,066,157−100.0% | Sold out |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −864,000−100.0% | Sold out |
| TPG GP A, LLC | 0 | $0 | 0.00% | −251,780−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −128,324−100.0% | Sold out |
| Hillsdale Investment Management Inc. | 0 | $0 | 0.00% | −86,531−100.0% | Sold out |
| EAM Investors, LLC | 0 | $0 | 0.00% | −58,202−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −42,977−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −36,302−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −10,374−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −9,786−100.0% | Sold out |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −872−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −149−100.0% | Sold out |